An Act to amend and reenact § 30-342 of the Code of Virginia, relating to Health Insurance Reform Commission; powers and duties.
HB826 amends the powers and duties of Virginia’s Health Insurance Reform Commission. The bill keeps the Commission focused on monitoring implementation of the federal Affordable Care Act and related state and federal agency actions, receiving and evaluating information about how health reform affects Virginia residents, businesses, and the state general fund, and developing recommendations for improving the Commonwealth’s health insurance system. It also preserves the Commission’s role in reviewing essential health benefits, mandated benefits and providers, and other health insurance proposals referred by legislative committee chairs.
The bill expands and clarifies the Commission’s advisory responsibilities by expressly directing it to assess proposed legislation that affects the cost of health insurance through changes to plan design or cost sharing, including impacts on consumers, employers, unions, and employee welfare benefit plans. It also continues the Commission’s authority to study mandated benefits and provider issues and to make recommendations intended to increase access to coverage, keep premiums and purchaser costs reasonable, and support a competitive health insurance market in Virginia.
HB826 amends § 30-342 of the Code of Virginia, updating the statutory list of the Health Insurance Reform Commission’s powers and duties. The practical effect is to reinforce the Commission’s role as an advisory body on health reform, insurance mandates, benefit design, and cost impacts, while preserving its authority to make recommendations to the General Assembly and administrative agencies. The bill does not itself mandate coverage or change insurance requirements directly, but it affects how future health insurance policy proposals are studied and evaluated in Virginia.
The available record shows no committee transcript or recorded vote details, so there is no direct evidence of debate or opposition in the materials provided. Based on the bill text, the measure appears to have been treated as a technical and policy-oriented update to an existing commission’s responsibilities rather than a controversial substantive overhaul. Its enactment as Chapter 675 suggests it ultimately received sufficient legislative support.
The main potential points of contention are the Commission’s continued involvement in evaluating federally influenced health reform, mandated benefits, and proposed legislation affecting plan design and cost sharing. Stakeholders who favor broader coverage mandates or stronger consumer protections may support the Commission’s review role, while insurers, employers, and other business interests may be attentive to the bill’s emphasis on controlling costs and limiting burdens on purchasers. Because the bill expands assessment of cost-sharing and plan-design legislation, disagreements could arise over how aggressively the Commission should recommend changes that affect premiums, benefits, and employer-sponsored coverage.